Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-24 Sale | 2024-09-26 8:35 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 503,000 | $11.66 | $5,866,308 | 1,277,178 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 4:07 pm | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 8,846 | $3.6895 | $32,637 | 46,069 (Direct) | View |
| 2023-09-28 Sale | 2023-10-02 9:05 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 6,896,144 | $11.55 | $79,650,463 | 5,023,787 (Indirect) | View |
| 2022-11-10 Sale | 2022-11-14 9:43 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 3,922,504 | $4.75 | $18,631,894 | 6,666,381 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-10 Option Award | 2024-09-12 9:00 pm | N/A 2034-09-09 | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 44,300 | $0 | 1,808,072 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:07 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 54,915 | $0.56 | 46,069 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:07 pm | N/A 2024-11-13 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 54,915 | $0 | 46,069 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:16 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2024-03-07 Other | 2024-03-07 6:35 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 30,257,723 | $0 | 34,784,621 (Indirect) | View |
| 2023-09-12 Option Award | 2023-09-14 9:30 pm | N/A 2033-09-11 | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 44,420 | $0 | 84,602,975 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 4:18 pm | 2023-05-24 2033-05-24 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-11-09 Other | 2022-11-14 9:43 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 1,196,200 | $0 | 6,666,381 (Indirect) | View |
| 2022-09-15 Option Award | 2022-09-19 9:53 pm | N/A 2032-09-14 | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 123,992 | $0 | 89,749,109 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:10 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 41,000 | $0 | 41,000 (Direct) | View |
Ownership | 2021-10-01 5:49 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 0 | $0 | 89,625,117 (Indirect) | View |
| 2021-06-03 Option Award | 2021-06-07 4:24 pm | 2021-06-03 2031-06-03 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-06-01 4:57 pm | 2020-05-28 2030-05-28 | Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director | 22,000 | $0 | 22,000 (Direct) | View |